|
Mera Pharmaceuticals, Inc. - Company Profile Snapshot
| Company Profile: |
Mera Pharmaceuticals, Inc. |
| Ticker: |
MRPI |
| Exchanges: |
OTC |
| 2008 Sales: |
609,980 |
| Major Industry: |
Drugs, Cosmetics & Health Care |
| Sub Industry: |
Diversified Drugs, Cosmetics, & Health Care |
| Country: |
UNITED STATES |
| Employees: |
6 |
Business Description
Mera Pharmaceuticals, Inc.. The Company's principal activities are to develop and commercialize natural products from microalgae using the large-scale photobioreactor technology known as Mera Growth Module (MGM). Its three operations are Natural Products,Contract services and Royalties. It uses its photobioreactor technology in the production and marketing of its first commercial product, ASTAFACTOR(R), a nutraceutical & source of natural astaxanthin. Its Trademarks & Service marks are SALMONESSENTIALS, AQUAXAN, MERA PHARMACEUTICALS, MERA GROWTH MODULE, MERA PROCESS CONTROL SYSTEM, MERA REMOTE DATA WEB ACCESS & DRUGS FROM THE SEA. The microalgae are known to contain valuable substances that have existing & potential commercial applications in fields such as animal and human nutrition, food colorings, cosmetics, diagnostic products, pharmaceuticals, research grade chemicals, pigments & dyes. It operates in the United States, Korea & Malaysia.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
